HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urotensin-II promotes vascular smooth muscle cell proliferation through store-operated calcium entry and EGFR transactivation.

AbstractAIMS:
Urotensin-II (UII) is a vasoactive peptide that promotes vascular smooth muscle cells (VSMCs) proliferation and is involved in the pathogenesis of atherosclerosis, restenosis, and vascular remodelling. This study aimed to determine the role of calcium (Ca(2+))-dependent signalling and alternative signalling pathways in UII-evoked VSMCs proliferation focusing on store-operated Ca(2+) entry (SOCE) and epithelium growth factor receptor (EGFR) transactivation.
METHODS AND RESULTS:
We used primary cultures of VSMCs isolated from Wistar rat aorta to investigate the effects of UII on intracellular Ca(2+) mobilization, and proliferation determined by the 5-bromo-2-deoxyuridine (BrdU) assay. We found that UII enhanced intracellular Ca(2+) concentration ([Ca(2+)]i) which was significantly reduced by classical SOCE inhibitors and by knockdown of essential components of the SOCE such as stromal interaction molecule 1 (STIM1), Orai1, or TRPC1. Moreover, UII activated a Gd(3+)-sensitive current with similar features of the Ca(2+) release-activated Ca(2+) current (ICRAC). Additionally, UII stimulated VSMCs proliferation and Ca(2+)/cAMP response element-binding protein (CREB) activation through the SOCE pathway that involved STIM1, Orai1, and TRPC1. Co-immunoprecipitation experiments showed that UII promoted the association between Orai1 and STIM1, and between Orai1 and TRPC1. Moreover, we determined that EGFR transactivation, extracellular signal-regulated kinase (ERK) and Ca(2+)/calmodulin-dependent kinase (CaMK) signalling pathways were involved in both UII-mediated Ca(2+) influx, CREB activation and VSMCs proliferation.
CONCLUSION:
Our data show for the first time that UII-induced VSMCs proliferation and CREB activation requires a complex signalling pathway that involves on the one hand SOCE mediated by STIM1, Orai1, and TRPC1, and on the other hand EGFR, ERK, and CaMK activation.
AuthorsMaría Rodríguez-Moyano, Ignacio Díaz, Natalia Dionisio, Xuexin Zhang, Javier Avila-Medina, Eva Calderón-Sánchez, Mohamed Trebak, Juan Antonio Rosado, Antonio Ordóñez, Tarik Smani
JournalCardiovascular research (Cardiovasc Res) Vol. 100 Issue 2 Pg. 297-306 (Nov 01 2013) ISSN: 1755-3245 [Electronic] England
PMID23933581 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Calcium Channels
  • Cyclic AMP Response Element-Binding Protein
  • Membrane Glycoproteins
  • ORAI1 Protein
  • Orai1 protein, rat
  • Receptors, G-Protein-Coupled
  • Stim1 protein, rat
  • Stromal Interaction Molecule 1
  • TRPC Cation Channels
  • Urotensins
  • Uts2r protein, rat
  • transient receptor potential cation channel, subfamily C, member 1
  • urotensin II
  • ErbB Receptors
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Extracellular Signal-Regulated MAP Kinases
  • Calcium
Topics
  • Animals
  • Calcium (metabolism)
  • Calcium Channels (physiology)
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 (physiology)
  • Cell Proliferation (drug effects)
  • Cyclic AMP Response Element-Binding Protein (metabolism)
  • ErbB Receptors (genetics)
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Male
  • Membrane Glycoproteins (physiology)
  • Muscle, Smooth, Vascular (cytology)
  • Myocytes, Smooth Muscle (physiology)
  • ORAI1 Protein
  • Phosphorylation
  • Rats
  • Rats, Wistar
  • Receptors, G-Protein-Coupled (physiology)
  • Signal Transduction
  • Stromal Interaction Molecule 1
  • TRPC Cation Channels (physiology)
  • Transcriptional Activation
  • Urotensins (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: